Cellcom Israel Ltd.

  • Market Cap: N/A
  • Industry: Telecom - Equipment & Accessories
  • ISIN: IL0011015349
ILS
31.11
-0.04 (-0.13%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

287.14 k

Shareholding (Mar 2026)

FII

0.31%

Held by 1 FIIs

DII

99.69%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 5.83%

  • Poor long term growth as Net Sales has grown by an annual rate of 1.66% and Operating profit at 57.56% over the last 5 years
  • The company is Net-Debt Free
2

With ROE of 21.23%, it has a Very Expensive valuation with a 1.99 Price to Book Value

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Telecom - Equipment & Accessories

stock-summary
Market cap

ILS 5,385 Million ()

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.43

stock-summary
Return on Equity

21.23%

stock-summary
Price to Book

1.99

Revenue and Profits:
Net Sales:
1,013 Million
(Quarterly Results - Mar 2026)
Net Profit:
72 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.93%
0%
-12.93%
6 Months
-16.77%
0%
-16.77%
1 Year
14.59%
0%
14.59%
2 Years
146.32%
0%
146.32%
3 Years
135.5%
0%
135.5%
4 Years
74.29%
0%
74.29%
5 Years
110.92%
0%
110.92%

Cellcom Israel Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
1.66%
EBIT Growth (5y)
57.56%
EBIT to Interest (avg)
1.54
Debt to EBITDA (avg)
1.94
Net Debt to Equity (avg)
0.71
Sales to Capital Employed (avg)
0.95
Tax Ratio
24.84%
Dividend Payout Ratio
70.93%
Pledged Shares
0
Institutional Holding
0.31%
ROCE (avg)
5.83%
ROE (avg)
4.75%

Valuation key factors

Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
1.99
EV to EBIT
16.33
EV to EBITDA
4.85
EV to Capital Employed
1.69
EV to Sales
1.58
PEG Ratio
0.06
Dividend Yield
0.00%
ROCE (Latest)
10.34%
ROE (Latest)
21.23%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.31%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -3.71% vs 1.84% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -80.22% vs 378.95% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,013.00",
          "val2": "1,052.00",
          "chgp": "-3.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "329.00",
          "val2": "328.00",
          "chgp": "0.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "23.00",
          "val2": "27.00",
          "chgp": "-14.81%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "72.00",
          "val2": "364.00",
          "chgp": "-80.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "105.60%",
          "val2": "69.40%",
          "chgp": "3.62%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -4.50% vs 1.05% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 226.01% vs 29.10% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4,244.00",
          "val2": "4,444.00",
          "chgp": "-4.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,346.00",
          "val2": "1,330.00",
          "chgp": "1.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "122.00",
          "val2": "143.00",
          "chgp": "-14.69%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.00",
          "val2": "-26.00",
          "chgp": "130.77%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "564.00",
          "val2": "173.00",
          "chgp": "226.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "90.70%",
          "val2": "86.90%",
          "chgp": "0.38%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
1,013.00
1,052.00
-3.71%
Operating Profit (PBDIT) excl Other Income
329.00
328.00
0.30%
Interest
23.00
27.00
-14.81%
Exceptional Items
0.00
0.00
Consolidate Net Profit
72.00
364.00
-80.22%
Operating Profit Margin (Excl OI)
105.60%
69.40%
3.62%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -3.71% vs 1.84% in Dec 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2026 is -80.22% vs 378.95% in Dec 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
4,244.00
4,444.00
-4.50%
Operating Profit (PBDIT) excl Other Income
1,346.00
1,330.00
1.20%
Interest
122.00
143.00
-14.69%
Exceptional Items
8.00
-26.00
130.77%
Consolidate Net Profit
564.00
173.00
226.01%
Operating Profit Margin (Excl OI)
90.70%
86.90%
0.38%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is -4.50% vs 1.05% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 226.01% vs 29.10% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details